BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Abbott Laboratories (ABT) Humira May Not be Effective in Colitis, FDA Says


8/24/2012 10:58:46 AM

Abbott Laboratories (ABT)’ rheumatoid arthritis drug Humira, the company’s top-selling product, may not be effective in treating ulcerative colitis in patients who don’t respond to conventional therapies, U.S. regulators said. While two trials on Humira’s use for moderate to severe ulcerative colitis met the studies’ goals, Food and Drug Administration staff in a report today questioned the “clinical meaningfulness” of a difference between patients’ reaction to the drug and a placebo. The staff also said limitations to the studies “introduced uncertainty” to the results.

Read at Bloomberg
Read at Reuters
Read at Fox News

Bloomberg
Reuters
Fox News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->